Ketamine has long been recognized for its anesthetic and analgesic properties. However, recent research has uncovered a revolutionary new application for this medication: treating depression. Spravato nasal spray, which delivers esketamine - an isomer of ketamine - directly to the brain, offers a unconventional approach to managing severe depressiv